Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma
Journal
Gastroenterology
Journal Volume
141
Journal Issue
4
Pages
1240
Date Issued
2011-10
Author(s)
Chen, Chuen-Fei
Yang, Hwai-I
Chang, Hung-Chuen
Jen, Chin-Lan
Iloeje, Uchenna H
Su, Jun
Wang, Li-Yu
You, San-Lin
Lu, Sheng-Nan
Chen, Chien-Jen
Abstract
It is not clear whether risk for hepatocellular carcinoma can be accurately determined from long-term changes in serum levels of hepatitis B virus (HBV) DNA or alanine aminotransferase (ALT).
Subjects
Liver Disease; Long-term Follow-up Study; Chronic Hepatitis B
SDGs
Other Subjects
alanine aminotransferase; virus DNA; adult; alanine aminotransferase blood level; article; cancer incidence; cancer risk; chronic hepatitis; controlled study; disease association; female; follow up; Hepatitis B virus; human; liver cell carcinoma; major clinical study; male; prediction; priority journal; virus carrier; virus load
Publisher
W B SAUNDERS CO-ELSEVIER INC
Type
journal article